Estimating health service utilization for treatment of pneumococcal disease: The case of Brazil

Background: Health service utilization (HSU) is an essential component of economic evaluations of health initiatives. Defining HSU for cases of pneumococcal disease (PD) is particularly complex considering the varying clinical manifestations and diverse severity. Objective: We describe the process of developing estimates of HSU for PD as part of an economic evaluation of the introduction of pneumococcal conjugate vaccine in Brazil. Methods: Nationwide inpatient and outpatient HSU by children under-5 years with meningitis (PM), sepsis (PS), non-meningitis non-sepsis invasive PD (NMNS), pneumonia, and acute otitis media (AOM) was estimated. We assumed that all cases of invasive PD (PM, PS, and NMNS) required hospitalization. The study perspective was the health system, including both the public and private sectors. Data sources were obtained from national health information systems, including the Hospital Information System (SIH/SUS) and the Notifiable Diseases Information System (SINAN); surveys; and community-based and health care facility-based studies. Results: We estimated hospitalization rates of 7.69 per 100,000 children under-5 years for PM (21.4 for children <1 years of age and 4.3 for children aged 1-4 years), 5.89 for PS (20.94 and 2.17), and 4.01 for NMNS (5.5 and 3.64) in 2004, with an overall hospitalization rate of 17.59 for all invasive PD (47.27 and 10.11). The estimated incidence rate of all-cause pneumonia was 93.4 per 1000 children under-5 (142.8 for children <1 years of age and 81.2 for children aged 1-4 years), considering both hospital and outpatient care. Discussion: Secondary data derived from health information systems and the available literature enabled the development of national HSU estimates for PD in Brazil. Estimating HSU for noninvasive disease was challenging, particularly in the case of outpatient care, for which secondary data are scarce. Information for the private sector is lacking in Brazil, but estimates were possible with data from the public sector and national population surveys.

Palavras-chave

Health service utilization, Pneumococcal disease, Meningitis, Sepsis, Acute otitis media

URI

https://observatorio.fm.usp.br/handle/OPI/2098

Referências

Ribeiro Manoel Carlos Sampaio de Almeida, 2006, Ciênc. saúde coletiva, V11, P1011, DOI 10.1590/S1413-81232006000400022
Andrade AL, 2012, VACCINE, V30, P1901, DOI 10.1016/j.vaccine.2011.12.012
Arévalo-Silva C A, 1999, Gac Med Mex, V135, P541
Barbieri M, 2010, VALUE HEALTH, V13, P1028, DOI 10.1111/j.1524-4733.2010.00771.x
Bardach A, 2011, INT J PEDIATR OTORHI, V75, P1062, DOI 10.1016/j.ijporl.2011.05.014
Bittencourt Sonia Azevedo, 2006, Cad Saude Publica, V22, P19, DOI 10.1590/S0102-311X2006000100003
Castro M., 2006, CIENC SAUDE COLETIVA, V11, P987, DOI 10.1590/S1413-81232006000400020
Cesar Juraci A, 2002, Cad Saude Publica, V18, P299, DOI 10.1590/S0102-311X2002000100030
Cherian T, 2005, J HEALTH POPUL NUTR, V23, P1
Constenla DO, 2008, REV PANAM SALUD PUBL, V24, P101
De Soarez PC, 2012, CAD SAUDE PUBLICA, V28, P211, DOI 10.1590/S0102-311X2012000200002
do Carmo GMI, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001024
Drummond M, 2009, VALUE HEALTH, V12, P409, DOI 10.1111/j.1524-4733.2008.00489.x
Empress Brasileira de Pesquisa Agropecuaria Centro Nacional de Pesquisa de Monitoramento por Satelite, 2006, MAP EST AR URB BRAS
Franco CM, 2004, VIGILANCIA PNEUMONIA
Giglio Norberto, 2011, Vaccine, V29 Suppl 3, pC35, DOI 10.1016/j.vaccine.2011.06.095
Giglio ND, 2010, VACCINE, V28, P2302, DOI 10.1016/j.vaccine.2009.12.070
HARVEY I, 1992, J EPIDEMIOL COMMUN H, V46, P329, DOI 10.1136/jech.46.4.329
Institut Brasileiro de Geografia e Estatistica, 2003, PESQ NAC AM DOM PNAD
Larraz GG, 2010, REV PANAM SALUD PUBL, V28, P92
Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2
Ministerio da Saude, 2006, DATASUS SIST INF HOS
Ministerio da Saude, 2012, SIST INF AGR NOT SIN
Ministerio da Saude, 2004, DATASUS IND DAD BAS
Ministerio da Saude Organizacao PanAamericana da Saude Fundacao Oswaldo Cruz, 2009, EXP BRAS SIST INF SA, V2
Ministerio da Saude Organizacao PanAamericana da Saude Fundacao Oswaldo Cruz, 2009, EXP BRAS SIST INF SA, VI
Nacul LC, 2005, J HEALTH POPUL NUTR, V23, P6
Nascimento-Carvalho CM, 2004, REV PANAM SALUD PUBL, V15, P380, DOI 10.1590/S1020-49892004000600003
Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
Presa J., 2009, J BRAS EC SAUDE, V1, P11
Ricetto AGL, 2003, REV CIENC MED CAMPIN, V12, P55
Sakano EWL, 2006, REV ASSOC MED BRAS, V52, P63
Nascimento-Carvalho Cristiana M C, 2002, Braz J Infect Dis, V6, P22, DOI 10.1590/S1413-86702002000100004
Sartori AMC, 2012, J EPIDEMIOL COMMUN H, V66, P210, DOI 10.1136/jech.2010.111880
Scott JAG, 2007, VACCINE, V25, P2398, DOI 10.1016/j.vaccine.2006.09.008
Sinha A, 2008, REV PANAM SALUD PUBL, V24, P304, DOI 10.1590/S1020-49892008001100002
Tonial SR, 1999, CAD SAUDE PUBLICA, V15, P749
Travassos C, 2008, J BRAS EPIDEMIOL, V11, P98
Uruena A, 2011, VACCINE, V29, P4963, DOI 10.1016/j.vaccine.2011.04.111
Valenzuela MT, 2009, REV PANAM SALUD PUBL, V25, P270, DOI 10.1590/S1020-49892009000300011
Vespa G, 2009, REV PANAM SALUD PUBL, V26, P518, DOI 10.1590/S1020-49892009001200007
Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0
VICTORA CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X
Werneck Cortes M, 2002, 1990 USO SISTEMAS IN
WHO, 1990, INT STAT CLASS DIS R

Coleções

Artigos e Materiais de Revistas Científicas - FM/MPR
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/39
Artigos e Materiais de Revistas Científicas - ODS/03

Página do item completo